 |
There are approximately 2.5 million people worldwide with MS.1 |
|
An estimated 400,000 people in the U.S. have MS.2 |
|
The likelihood of the average person living in the U.S. to develop MS is about 1 in 750.2 |
|
The onset of MS is typically around the age of 30.4 |
|
The incidence of MS is 2 times higher in women than in men.3 |
|
MS is more common among Caucasians than other races.3 |
|
African Americans with MS are more likely to experience a more severe course of disease progression.5 |
|
MS occurs with greater frequency in colder locations with latitudes above 40°. In tropical climates and other areas close to the equator, MS is less prevalent.2 |
|
MS is the most common chronic disabling disease of the central nervous system in young adults.1 |
|
People diagnosed with MS are more prone to clinical depression.6 |
|
Though MS is a lifelong disease, people with MS have a life expectancy that is close to the life expectancy of those without MS.7 |
|
Statistically 2 out of 3 people diagnosed with MS remain able to walk throughout their lifetime. The other third, may need some sort of assistive device such as a cane.8 |
|
Studies suggest that patients starting a disease modifying therapy from the onset receive maximal benefit than those who don’t. Early adherence slows disease progression.9 |
|
Most of the disease-modifying therapies have been shown to be effective in the long term.9 |
